Clinical effects of ursodeoxycholic acid in COVID-19 infection: a systematic review and dose-response meta-analysis. [PDF]
Song JH +8 more
europepmc +1 more source
Ursodeoxycholic acid for the treatment of cholestasis in newborn infants. [PDF]
Bolisetty V +4 more
europepmc +1 more source
Ursodeoxycholic acid treatment did not show protective effect for severe COVID-19 outcomes - a nationwide register study. [PDF]
Li H +4 more
europepmc +1 more source
A novel ursodeoxycholic acid derivative exhibits broad-spectrum antiviral activity against influenza A virus and coronaviruses by multiphasic disruption of the viral life cycle. [PDF]
Peng Z +6 more
europepmc +1 more source
Biosynthesis of tauro-ursodeoxycholic acid (TUDCA) in Saccharomyces cerevisiae. [PDF]
Moon S, Smanski MJ.
europepmc +1 more source
Ursodeoxycholic acid mitigates cerebral ischemia/reperfusion injury by inhibiting thrombin-induced lipid peroxidation through activation of ALDH3A1. [PDF]
Liu A +7 more
europepmc +1 more source
Clinicopathological features of hepatobiliary cells in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid. [PDF]
Yang K +12 more
europepmc +1 more source
Ursodeoxycholic acid inhibits pneumonia caused by PRCV through the activation of TLR4-IRF3 mediated type Ⅰ interferon pathway. [PDF]
Zhang X +7 more
europepmc +1 more source
Advances in Pharmacological Activities, Biosynthesis, and Structural Modification of Ursodeoxycholic Acid (UDCA): A Review. [PDF]
Li P +5 more
europepmc +1 more source

